Happy Thanksgiving to all!

We're taking the day off on Thursday, the day we normally distribute our second newsletter of the week. But thankfully, we've prepared a special "Best of FiercePharmaManufacturing" issue so you can review some of the highlights of the last year.

You'll find the "Best of" issue in your in-box tomorrow morning, for review before you head out for the holiday. Enjoy! - George Miller (email)

Suggested Articles

AbbVie will soon own Allergan’s prized Botox franchise, and along with its roughly $4 billion in sales, it will get a new $176 million plant.

Merck KGaA has big plans for a site in Switzerland where it intends to knit together biologics development and manufacturing. 

The FDA has found some issues with Biocon’s small molecule plant in Bengaluru, India.